Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-28

Clinical Trial Update: A Pilot Study Assessing EmSam in Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating EmSam for bipolar depression was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EMSAM (selegiline)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Bipolar Depression | Phase 4 | Status: TERMINATED | Results posted: 2014-10-28